Abstract:Gene dosage variations occur in many diseases. In cancer, deletions and copy number increases contribute to alterations in the expression of tumour-suppressor genes and oncogenes, respectively. Developmental abnormalities, such as Down, Prader Willi, Angelman and Cri du Chat syndromes, result from gain or loss of one copy of a chromosome or chromosomal region. Thus, detection and mapping of copy number abnormalities provide an approach for associating aberrations with disease phenotype and for localizing critical genes. Comparative genomic hybridization3(CGH) was developed for genome-wide analysis of DNA sequence copy number in a single experiment. In CGH, differentially labelled total genomic DNA from a 'test' and a 'reference' cell population are cohybridized to normal metaphase chromosomes, using blocking DNA to suppress signals from repetitive sequences. The resulting ratio of the fluorescence intensities at a location on the 'cytogenetic map', provided by the chromosomes, is approximately proportional to the ratio of the copy numbers of the corresponding DNA sequences in the test and reference genomes. CGH has been broadly applied to human and mouse malignancies. The use of metaphase chromosomes, however, limits detection of events involving small regions (of less than 20 Mb) of the genome, resolution of closely spaced aberrations and linking ratio changes to genomic/genetic markers. Therefore, more laborious locus-by-locus techniques have been required for higher resolution studies2,3,4,5. Hybridization to an array of mapped sequences instead of metaphase chromosomes could overcome the limitations of conventional CGH (ref. 6) if adequate performance could be achieved. Copy number would be related to the test/reference fluorescence ratio on the array targets, and genomic resolution could be determined by the map distance between the targets, or by the length of the cloned DNA segments. We describe here our implementation of array CGH. We demonstrate its ability to measure copy number with high precision in the human genome, and to analyse clinical specimens by obtaining new information on chromosome 20 aberrations in breast cancer.

Scanning The Human Genome At Kilobase Resolution

Simplified DGS Procedure for Large-Scale Genome Structural Study

Scanning the human genome at kilobase resolution data

Large-scale Genotyping of Complex DNA

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

Restriction Landmark Genomic Scanning (RLGS) spot identification by second generation virtual RLGS in multiple genomes with multiple enzyme combinations

Rapid Detection of Structural Variation in a Human Genome Using Nanochannel-Based Genome Mapping Technology.

Scanning the human genome at kilobase resolution Material Supplemental

Multi-platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes

Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome

Direct genome-wide identification of G-quadruplex structures by whole-genome resequencing

Detecting Structural Variations in the Human Genome Using Next Generation Sequencing

Assessing structural variation in a personal genome—towards a human reference diploid genome

High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

Mapping and characterization of structural variation in 17,795 human genomes

Characterization of Large-Scale Genomic Differences in the First Complete Human Genome

Monitoring Genomic Structural Rearrangements Resulting from Gene Editing

Modeling Kinetic Rate Variation in Third Generation DNA Sequencing Data to Detect Putative Modifications to DNA Bases

Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons

Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes

DNAscan: a fast, computationally and memory efficient bioinformatics pipeline for the analysis of DNA next-generation-sequencing data